The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
about
Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like propertiesMolecular biology of lung cancer: clinical implicationsCD133: to be or not to be, is this the real question?Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem CellsEsophageal cancer stem cells and implications for future therapeuticsLung cancer stem cells and low-intensity laser irradiation: a potential future therapy?Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and PerspectivesIn vitro models of cancer stem cells and clinical applicationsCancer stem cells in basic science and in translational oncology: can we translate into clinical application?Transcriptome sequencing of tumor subpopulations reveals a spectrum of therapeutic options for squamous cell lung cancerSmall nucleolar RNA signatures of lung tumor-initiating cellsThe multiple facets of drug resistance: one history, different approaches.Lung cancer stem cell: new insights on experimental models and preclinical data.Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy.Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line.Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formationMatrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential.ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinomaResidual tumor cells that drive disease relapse after chemotherapy do not have enhanced tumor initiating capacity.Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.G protein-coupled receptor 87 (GPR87) promotes the growth and metastasis of CD133⁺ cancer stem-like cells in hepatocellular carcinomaCancer stem cell radioresistance and enrichment: where frontline radiation therapy may fail in lung and esophageal cancersIdentification of a novel subpopulation of tumor-initiating cells from gemcitabine-resistant pancreatic ductal adenocarcinoma patients.High CD133 expression in the nucleus and cytoplasm predicts poor prognosis in non-small cell lung cancerProgesterone and estrogen receptor expression and activity in human non-small cell lung cancerProtein kinase C-δ inactivation inhibits the proliferation and survival of cancer stem cells in culture and in vivoHuman non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cellsIs CD133 expression a prognostic biomarker of non-small-cell lung cancer? A systematic review and meta-analysis.Evidence that RASSF1C stimulation of lung cancer cell proliferation depends on IGFBP-5 and PIWIL1 expression levels.Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.Differential remodeling of extracellular matrices by breast cancer initiating cells.Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.The crossroads between cancer stem cells and aging.Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacityRole of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells.Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation.Stem cells and regenerative medicine in lung biology and diseases.Targeted therapies for lung cancer: clinical experience and novel agentsHigh-level expression of stem cell marker CD133 in clear cell renal cell carcinoma with favorable prognosis.
P2860
Q21562142-D7900CFA-2D6D-4A5D-833C-CB2E772C031AQ24610335-B1899653-AE41-47AC-8236-967177B340DDQ24615405-80EBEBFD-3F0A-4BBC-84BF-C4E2B3F2CF5CQ26744724-619FF3FA-4134-44DF-96DC-83E5528D5B48Q26752943-9CD70081-857C-4438-870A-3AF96D1ED95BQ27021829-AE82396B-CA6E-46B7-9D42-89AFAF92A3A8Q28071388-23F32040-6D7B-48CC-8D57-34CA859244F5Q28076101-9EB5D9B1-16E3-4F1E-A434-8A1010427CDAQ28081844-6355320A-DCFC-4989-92A5-AF66B3788457Q28488566-2B3EAEF6-7AE7-48E5-93CB-EB34EB132EFBQ33646165-4B389D0A-E78D-4DD1-954B-4C0C8D48F49CQ33697116-31F32D63-951F-46E2-8C2C-4A16EEA71CF4Q33786637-CC4D04D0-BE0A-4688-ABF6-D7432B1693E7Q33829820-EA9E27C7-D6D3-4894-9A0F-2BE0813B9562Q33955042-2D79D3CE-7A43-4B1E-A008-64FD362AA64AQ34056327-4E688991-378E-43AB-951E-4A2899471AE0Q34251083-06D196E0-26DB-4129-B2AB-F8837CB2AB5CQ34343153-4E3435E4-F737-4A59-90CF-8A6F5028609AQ34463435-3D661EB9-1A3F-4746-8168-5C6FAB8A4A89Q34562736-F9DC4E6C-1511-4AB0-9C28-5A81E8A0D5C0Q34674548-A8031811-9FEA-4974-81E6-F03926C9D001Q34985594-683A8BAC-B868-4B01-95EC-5CCBB4797F4DQ35053973-66CB05B0-87D3-4AD5-A689-368207B3F95DQ35068234-A05CBD61-3A9E-4DEB-8654-2BC613759A56Q35085764-08F46AD7-3AFA-4549-B5C4-E4E518DA8CE3Q35094509-D314052A-09C9-4E5E-B1DE-5AFFA86CF6F5Q35147451-9C7E6071-D033-48B5-BF21-4FB48274E577Q35190239-321A5E27-EADD-4130-87D5-C1BE3F43ADCCQ35203738-0D997B19-52A0-4CDE-A95C-C9EC944F9197Q35532904-188347CD-E4A4-41BB-96EE-0AFC109565B2Q35544277-1EC9C0E5-8A47-4BB0-85AC-12CC3BBCAC68Q35550185-96956428-4B66-47FD-AB16-4891DA60E25AQ35566484-3448F66C-C649-4D7A-A6BE-9227B66CA99BQ35632597-5F73F62E-C5D7-4837-A01F-9003F4BE4586Q35734750-E9906955-A8D4-48F3-8877-CA6FAEBECDEAQ35745018-3E21EA89-07B5-4448-8DEE-A0912FC82117Q35757920-E62EFCCB-C92A-4CB3-8799-57035943C851Q36014064-6E9BF07F-81A9-4BFA-B474-9EF25B4107D6Q36054970-56F057A9-F666-4FA0-9E6E-C4D1EFD3FE8AQ36121660-D325B8B6-C77B-499D-B9D8-B7E95FBC4163
P2860
The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The role of CD133 in the ident ...... in non-small-cell lung cancer.
@ast
The role of CD133 in the ident ...... in non-small-cell lung cancer.
@en
type
label
The role of CD133 in the ident ...... in non-small-cell lung cancer.
@ast
The role of CD133 in the ident ...... in non-small-cell lung cancer.
@en
prefLabel
The role of CD133 in the ident ...... in non-small-cell lung cancer.
@ast
The role of CD133 in the ident ...... in non-small-cell lung cancer.
@en
P50
P1476
The role of CD133 in the ident ...... in non-small-cell lung cancer.
@en
P2093
Giuseppe Pirozzi
Giuseppe Viglietto
P304
P356
10.1016/J.EJCTS.2009.03.063
P577
2009-05-22T00:00:00Z